Yıl: 2022 Cilt: 37 Sayı: 3 Sayfa Aralığı: 314 - 320 Metin Dili: İngilizce DOI: 10.5505/tjo.2022.3522 İndeks Tarihi: 05-05-2023

Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer

Öz:
The aim of this study was to evaluate the compatibility of tumor grades in pre-operative biopsies, frozen sections and post-operative specimens and to evaluate the adequacy of a selective surgical staging policy based on information obtained from intra-operative frozen sections to avoid lymphadenectomy in patients with endometrial cancer (EC). METHODS Ninety patients diagnosed with EC were analyzed. Fifty-four patients were at Stage I (60%), 19 were at Stage II (21%) and 17 (19%) were at Stage III. Fifty-four patients (60%) had grades on pre-operative biopsies, 31 patients (34%) had grades on frozen sections and 88 patients (98%) had grades on postoperative specimens. Depth of myometrial invasion was reported in 54 patients (60%) based on frozen sections and in all patients on post-operative specimens. Eight patients (9%) underwent no lymphadenectomy, 32 patients (36%) underwent pelvic lymphadenectomy and 50 patients (55%) underwent pelvic and para-aortic lymphadenectomy. RESULTS There were five patients for whom tumors were up-graded when pre-operative biopsies and frozen sections were. There were 17 patients for whom tumors were up-graded and four patients for whom tumors were down-graded when pre-operative biopsies and post-operative specimens were compared. There were six patients for whom tumors were up-graded when frozen sections and post-operative specimens were compared and the distribution of patients between intra-operatively and post-operatively assigned tumor grade groups was statistically significant. CONCLUSION For surgeons who do not perform complete surgical staging for every patient with EC, clinical judgment should only be efficient when augmented with information obtained from frozen sections.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424.
  • 2. Sherman ME, Sturgeon S, Brinton LA, Potischman N, Kurman RJ, Berman ML, et al. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol 1997;10(10):963–8.
  • 3. Maneschi F, Ceccacci I, Perugini A, Pane C, Simeone A, Manicone A. Endometrial cancer: prognostic significance of risk classification based on pre-intraoperative findings. Arch Gynecol Obstet 2012;285(2):521–7.
  • 4. Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al; ESMO-ESGOESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow- up. Ann Oncol 2016;27(1):16–41.
  • 5. Visser NCM, Reijnen C, Massuger L, Nagtegaal ID, Bulten J, Pijnenborg JMA. Accuracy of Endometrial Sampling in Endometrial Carcinoma: A Systematic Review and Meta-analysis. Obstet Gynecol 2017;130(4):803–13.
  • 6. Batista TP, Cavalcanti CL, Tejo AA, Bezerra AL. Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma. Eur J Surg Oncol 2016;42(9):1367–71.
  • 7. Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GECESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235–45.
  • 8. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987;60(S8):2035–41.
  • 9. DiSaia P, Creasman W, Boronow R, Blessing J. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol 1985;151(8):1009–15.
  • 10. Burger MP. Management of stage 1 endometrial carcinoma: Postoperative radiotherapy is not justified in women with medium risk disease. BMJ 2001;322(7286):568–9.
  • 11. Stephan JM, Hansen J, Samuelson M, McDonald M, Chin Y, Bender D, et al. Intra-operative frozen section results reliably predict final pathology in endometrial cancer. Gynecol Oncol 2014;133(3):499–505.
  • 12. Kumar S, Bandyopadhyay S, Semaan A, Shah JP, Mahdi H, Morris R, et al. The role of frozen section in surgical staging of low risk endometrial cancer. PLoS One 2011;6(9):e21912.
  • 13. Helpman L, Kupets R, Covens A, Saad RS, Khalifa MA, Ismiil N, et al. Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer. Br J Cancer 2014;110(3):609–15.
  • 14. Gitas G, Proppe L, Alkatout I, Rody A, Kotanidis C, Tsolakidis D, et al. Accuracy of frozen section at early clinical stage of endometrioid endometrial cancer: a retrospective analysis in Germany. Arch Gynecol Obstet 2019;300(1):169–74.
  • 15. Quinlivan JA, Petersen RW, Nicklin JL. Accuracy of frozen section for the operative management of endometrial cancer. Br J Obstet Gynaecol 2001;108(8):798–803.
  • 16. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56(4):419–27.
  • 17. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40(1):55–65.
  • 18. Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, et al. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg 2004;199(3):388–93.
  • 19. Bezerra ALR, Batista TP, Martins MR, Carneiro VCG. Surgical treatment of clinically early-stage endometrial carcinoma without systematic lymphadenectomy. Rev Assoc Med Bras 2014;60(6):571–6.
  • 20. Bouche C, Gomes David M, Salleron J, Rauch P, Leufflen L, Buhler J, et al. Evaluation of Pre-Therapeutic Assessment in Endometrial Cancer Staging. Diagnostics 2020;10(12):1045.
APA Halis H, Ay Ö, ERKAL H (2022). Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer. , 314 - 320. 10.5505/tjo.2022.3522
Chicago Halis Hatice,Ay Özlem,ERKAL HALDUN SÜKRÜ Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer. (2022): 314 - 320. 10.5505/tjo.2022.3522
MLA Halis Hatice,Ay Özlem,ERKAL HALDUN SÜKRÜ Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer. , 2022, ss.314 - 320. 10.5505/tjo.2022.3522
AMA Halis H,Ay Ö,ERKAL H Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer. . 2022; 314 - 320. 10.5505/tjo.2022.3522
Vancouver Halis H,Ay Ö,ERKAL H Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer. . 2022; 314 - 320. 10.5505/tjo.2022.3522
IEEE Halis H,Ay Ö,ERKAL H "Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer." , ss.314 - 320, 2022. 10.5505/tjo.2022.3522
ISNAD Halis, Hatice vd. "Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer". (2022), 314-320. https://doi.org/10.5505/tjo.2022.3522
APA Halis H, Ay Ö, ERKAL H (2022). Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer. Türk Onkoloji Dergisi, 37(3), 314 - 320. 10.5505/tjo.2022.3522
Chicago Halis Hatice,Ay Özlem,ERKAL HALDUN SÜKRÜ Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer. Türk Onkoloji Dergisi 37, no.3 (2022): 314 - 320. 10.5505/tjo.2022.3522
MLA Halis Hatice,Ay Özlem,ERKAL HALDUN SÜKRÜ Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer. Türk Onkoloji Dergisi, vol.37, no.3, 2022, ss.314 - 320. 10.5505/tjo.2022.3522
AMA Halis H,Ay Ö,ERKAL H Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer. Türk Onkoloji Dergisi. 2022; 37(3): 314 - 320. 10.5505/tjo.2022.3522
Vancouver Halis H,Ay Ö,ERKAL H Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer. Türk Onkoloji Dergisi. 2022; 37(3): 314 - 320. 10.5505/tjo.2022.3522
IEEE Halis H,Ay Ö,ERKAL H "Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer." Türk Onkoloji Dergisi, 37, ss.314 - 320, 2022. 10.5505/tjo.2022.3522
ISNAD Halis, Hatice vd. "Compatibility of Tumor Grades in Pre-Operative Biopsies, Frozen Sections, and Post-Operative Specimens in Patients with Endometrial Cancer". Türk Onkoloji Dergisi 37/3 (2022), 314-320. https://doi.org/10.5505/tjo.2022.3522